Healthcare -
Biotechnology - NASDAQ - US
$ 7.37
3.08 %
$ 365 M
Market Cap
-1.47
P/E
RGNX - CASH FROM OPERATIONS
Cash from Operations RGNX - REGENXBIO Inc.
-218 M
LAST VALUE
-41.35%
2 YEAR CAGR
-25.29%
5 YEAR CAGR
-53.48%
10 YEAR CAGR